From: Serum magnesium, mortality and disease progression in chronic kidney disease
Magnesium | All-cause unadjusted HR (95% CI) | All-cause HR (95% CI)* | Cardiovascular SHR (95% CI)* | Malignancy SHR (95% CI)* | Non-cardio non-malignancy causes SHR (95% CI)* |
---|---|---|---|---|---|
All patients | |||||
< 1.7 mg/dl | 1.14 (1.05, 1.24) | 1.14 (1.04, 1.24) | 0.91 (0.76, 1.08) | 1.14 (0.97, 1.33) | 1.29 (1.12, 1.49) |
1.7–2.6 mg/dl | Ref | Ref | Ref | Ref | Ref |
> 2.6 mg/dl | 1.44 (1.20, 1.72) | 1.23 (1.03, 1.48) | 1.11 (0.81, 1.51) | 0.71 (0.41, 1.22) | 1.26 (0.93, 1.71) |